These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6193232)

  • 1. Regulatory mechanisms in cell-mediated immune responses. Role of I-J and I-C determinants in the activation of H-2I and H-2K/D alloantigen-specific suppressor T cells.
    Rich S
    J Exp Med; 1983 Sep; 158(3):738-51. PubMed ID: 6193232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and antigenic requirements for production of mixed leukocyte reaction suppressor factor.
    Dennison DK; Rich SS; Rich RR
    J Immunol; 1981 Nov; 127(5):2176-82. PubMed ID: 6457865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms in cell-mediated immune responses. VIII. Differential expression of I-region determinants by suppressor cells and their targets in suppression of mixed leukocyte reactions.
    Rich SS; David CS
    J Exp Med; 1979 Nov; 150(5):1108-21. PubMed ID: 91654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules.
    Glimcher LH; Longo DL; Green I; Schwartz RH
    J Exp Med; 1981 Nov; 154(5):1652-70. PubMed ID: 6170721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2.
    Rich S; Carpino MR; Arhelger C
    J Exp Med; 1984 May; 159(5):1473-90. PubMed ID: 6201587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory mechanisms in cell-mediated immune responses. VII. Presence of I-C subregion determinants on mixed leukocyte reaction suppressor factor.
    Rich SS; David CS; Rich RR
    J Exp Med; 1979 Jan; 149(1):114-26. PubMed ID: 84040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ia-positive stimulator cells are required in primary, but not in secondary, mixed leukocyte reactions against H-2K and H-2D differences.
    Minami M; Shreffler DC
    J Immunol; 1981 May; 126(5):1774-9. PubMed ID: 6452478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cells.
    Bradley SM; Kruisbeek AM; Singer A
    J Exp Med; 1982 Dec; 156(6):1650-64. PubMed ID: 6217271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.
    Sprent J; Schaefer M
    J Exp Med; 1985 Dec; 162(6):2068-88. PubMed ID: 2933483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens.
    Holán V; Mitchison NA
    Eur J Immunol; 1983 Aug; 13(8):652-7. PubMed ID: 6192999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine CD8+ T suppressors against mycobacterial 65-kDa antigen compete for IL-2 and show lack of major histocompatibility complex-imposed restriction specificity in antigen recognition.
    Khetan S; Sainis KB; Rath S; Kamat R
    Eur J Immunol; 1993 Oct; 23(10):2440-7. PubMed ID: 8405043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
    Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
    Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.